Literature DB >> 21281098

Intrauterine contraceptives that do not fit well contribute to early discontinuation.

Dirk Wildemeersch1.   

Abstract

BACKGROUND: To shed additional light on various aspects of intrauterine contraception discussed recently in a comprehensive review article and on the continued development of frameless copper intrauterine devices (IUDs). CONTENT: An essential feature of intrauterine contraceptives is their long duration of action. However, this only applies in the absence of side effects. The importance of dimensional compatibility of the IUD or intrauterine system (IUS) with the uterine cavity should be stressed: IUD/IUS designs that fit will lead to high acceptability, a prerequisite with regard to continuation of use. Dimensional incompatibility, on the other hand, is a cause of cramping pain, erratic bleeding or menorrhagia, dislocation or expulsion and, as a result thereof, pregnancy. The size of the intrauterine foreign body, in relation to that of the uterine cavity, determines its acceptability and influences menstrual bleeding. Abnormal and heavy menstrual bleeding is an issue which has not been fully resolved. It is the most common cause of discontinuation of this contraceptive modality. The size of the IUD can be reduced without jeopardizing its effectiveness provided the effective copper surface is sufficiently large.
CONCLUSION: Properly designed and fitting IUDs and IUSs are associated with fewer side effects and greater user satisfaction. This, in turn, could increase usage of intrauterine contraception and thus reduce further the number of unintented pregnancies and induced abortions.

Entities:  

Mesh:

Year:  2011        PMID: 21281098     DOI: 10.3109/13625187.2010.546533

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  4 in total

1.  Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial.

Authors:  David Hubacher; Courtney A Schreiber; David K Turok; Jeffrey T Jensen; Mitchell D Creinin; Kavita Nanda; Katharine O'Connell White; Ila Dayananda; Stephanie B Teal; Pai-Lien Chen; Beatrice A Chen; Alisa B Goldberg; Jennifer L Kerns; Clint Dart; Anita L Nelson; Michael A Thomas; David F Archer; Jill E Brown; Paula M Castaño; Anne E Burke; Bliss Kaneshiro; Diana L Blithe
Journal:  EClinicalMedicine       Date:  2022-07-16

2.  Trends and factors associated with long-acting reversible contraception in Kenya.

Authors:  Wambui Kungu; Anne Khasakhala; Alfred Agwanda
Journal:  F1000Res       Date:  2020-05-20

3.  Role of uterine forces in intrauterine device embedment, perforation, and expulsion.

Authors:  Norman D Goldstuck; Dirk Wildemeersch
Journal:  Int J Womens Health       Date:  2014-08-07

Review 4.  Femilis(®) 60 Levonorgestrel-Releasing Intrauterine System-A Review of 10 Years of Clinical Experience.

Authors:  Dirk Wildemeersch; Amaury Andrade; Norman Goldstuck
Journal:  Clin Med Insights Reprod Health       Date:  2016-08-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.